Protective Effectiveness of Inactivated Hantavirus Vaccine Against Hemorrhagic Fever With Renal Syndrome
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jung, Jaehun | - |
dc.contributor.author | Ko, Sung-Jun | - |
dc.contributor.author | Oh, Hong Sang | - |
dc.contributor.author | Moon, Song Mi | - |
dc.contributor.author | Song, Jin-Won | - |
dc.contributor.author | Huh, Kyungmin | - |
dc.date.accessioned | 2021-09-02T11:41:08Z | - |
dc.date.available | 2021-09-02T11:41:08Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2018-05-01 | - |
dc.identifier.issn | 0022-1899 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/75586 | - |
dc.description.abstract | As there is no effective treatment against hemorrhagic fever with renal syndrome (HFRS), the development of effective vaccine is important. An inactivated hantavirus vaccine (IHV) has been used in Korea, but there has been controversy regarding its effectiveness. We conducted a case-control study to evaluate the vaccine effectiveness (VE) of IHV against HFRS in the Korean military. Unadjusted and adjusted VEs of IHV were 59.1% and 58.9%, respectively. VE was higher in divisions with high incidence of HFRS (unadjusted VE, 71.4%; adjusted VE, 78.7%). Our study demonstrated the moderate effectiveness of IHV in high-risk populations residing in endemic area. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | OXFORD UNIV PRESS INC | - |
dc.subject | HANTAVAX(R) | - |
dc.subject | RESPONSES | - |
dc.subject | KOREA | - |
dc.title | Protective Effectiveness of Inactivated Hantavirus Vaccine Against Hemorrhagic Fever With Renal Syndrome | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Song, Jin-Won | - |
dc.identifier.doi | 10.1093/infdis/jiy037 | - |
dc.identifier.scopusid | 2-s2.0-85050749672 | - |
dc.identifier.wosid | 000430729300012 | - |
dc.identifier.bibliographicCitation | JOURNAL OF INFECTIOUS DISEASES, v.217, no.9, pp.1417 - 1420 | - |
dc.relation.isPartOf | JOURNAL OF INFECTIOUS DISEASES | - |
dc.citation.title | JOURNAL OF INFECTIOUS DISEASES | - |
dc.citation.volume | 217 | - |
dc.citation.number | 9 | - |
dc.citation.startPage | 1417 | - |
dc.citation.endPage | 1420 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Immunology | - |
dc.relation.journalResearchArea | Infectious Diseases | - |
dc.relation.journalResearchArea | Microbiology | - |
dc.relation.journalWebOfScienceCategory | Immunology | - |
dc.relation.journalWebOfScienceCategory | Infectious Diseases | - |
dc.relation.journalWebOfScienceCategory | Microbiology | - |
dc.subject.keywordPlus | HANTAVAX(R) | - |
dc.subject.keywordPlus | RESPONSES | - |
dc.subject.keywordPlus | KOREA | - |
dc.subject.keywordAuthor | hantavirus | - |
dc.subject.keywordAuthor | vaccine | - |
dc.subject.keywordAuthor | hemorrhagic fever with renal syndrome | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.